BCL2L1 and pancreatic endocrine carcinoma: More recently, the same RIP-Bcl-xL transgene has also been shown to suppress apoptosis in another mouse model of islet cell carcinoma, in which a myc fusion protein, mycTAM, was expressed in the β-cells under the control of the rat insulin promoter [20].